Live Cell Imaging Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032
Download as PPTX, PDF0 likes72 views
The global live cell imaging market is projected to grow from $2.3 billion in 2023 to $4.6 billion by 2032, driven by increased adoption for studying cellular processes and innovations in medical research. The market growth is supported by advancements in imaging technology, rising chronic disease prevalence, and government investments in healthcare infrastructure. Key players include Becton Dickinson, Carl Zeiss, and Thermo Fisher Scientific.
Live Cell Imaging Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032
- 1. Global Live Cell Imaging Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved
- 2. About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
- 3. Report Highlight and Description According to the latest report by IMARC Group, titled "Live Cell Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," the global live cell imaging market size reached US$ 2.3 Billion in 2023. Live cell imaging refers to the process of observing and recording living cells using specialized microscopes and imaging techniques. It is used to study the behavior, function, and interactions of cells in real-time, under physiological conditions. It is also employed to visualize various cellular processes such as cell division, migration, signaling, differentiation, and apoptosis. In addition, it allows researchers to track changes in the morphology, dynamics, and localization of cellular components over time. Over the years, live cell imaging has become an essential tool in biological research, enabling scientists to gain insights into the mechanisms underlying cellular processes and to develop new treatments for diseases. Request for a PDF sample of this report: https://www.imarcgroup.com/live- cell-imaging-market/requestsample
- 4. Report Description Global Live Cell Imaging Market Trends: The market is primarily driven by the rising product adoption studying proteins and molecular interactions. In addition, various innovations in medical research aimed at developing new drugs and therapies for life-threatening conditions, and the rising prevalence of numerous chronic diseases caused by sedentary lifestyles, represent other major growth-inducing factors. Besides this, the increasing utilization of high-content screening (HCS) to improve the drug development process, reduce toxicity, and save time and costs is also contributing to the market growth. Moreover, government agencies of several countries are investing in healthcare infrastructure and developing advanced surgical procedures to provide better treatment for patients. This, coupled with the growing applications of live cell imaging in research laboratories to maintain cell viability is propelling the market growth. Furthermore, the development of advanced live cell imaging techniques with improved camera technology, sensitivity, and pixel density is creating a favorable market outlook across the globe. Looking forward, IMARC Group expects the market value to reach US$ 4.6 Billion by 2032, exhibiting a CAGR of 7.7% during the forecast period (2024-2032). View Report TOC, Figures and Tables: https://www.imarcgroup.com/live-cell-imaging-market
- 5. Report Segmentation Product Insights: • Equipment • Consumable • Software Application Insights: • Cell Biology • Developmental Biology • Stem Cell and Drug Discovery • Others Technology Insights: • Time-Lapse Microscopy • Fluorescence Recovery after Photobleaching (FRAP)
- 6. Report Segmentation • Fluorescence Resonance Energy Transfer (FRET) • High Content Screening (HCS) • Others Breakup by Region: • North America • Asia-Pacific • Europe • Latin America • Middle East and Africa
- 7. Competitive Landscape with Key Players • Becton Dickinson and Company (BD) • Carl Zeiss AG • Leica Microsystems (Danaher Corporation) • Merck KGaA • Nikon Instruments Inc. • Olympus Corporation • PerkinElmer Inc. • Thermo Fisher Scientific Inc.
- 8. Key Questions Answered in the Report What was the size of the global live cell imaging market in 2023? What is the expected growth rate of the global live cell imaging market during 2024-2032? What are the key factors driving the global live cell imaging market? What has been the impact of COVID-19 on the global live cell imaging market? What is the breakup of the global live cell imaging market based on the product? What is the breakup of the global live cell imaging market based on the application? What is the breakup of the global live cell imaging market based on the technology? What are the key regions in the global live cell imaging market? Who are the key players/companies in the global live cell imaging market?
- 9. Table of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Live Cell Imaging Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Equipment 6.1.1 Market Trends 6.1.2 Mark et Forecast 6.2 Consumable 6.2.1 Mark et Trends 6.2.2 Mark et Forecast 6.3 Software 6.3.1 Mark et Trends 6.3.2 Mark et Forecast 7 Market Breakup by Application
- 10. Table of Contents 7.1 Cell Biology 7.1.1 Mark et Trends 7.1.2 Mark et Forecast 7.2 Developmental Biology 7.2.1 Mark et Trends 7.2.2 Mark et Forecast 7.3 Stem Cell and Drug Discovery 7.3.1 Mark et Trends 7.3.2 Mark et Forecast 7.4 Others 7.4.1 Mark et Trends 7.4.2 Mark et Forecast 8 Market Breakup by Technology 8.1 Time-Lapse Microscopy 8.1.1 Mark et Trends 8.1.2 Mark et Forecast 8.2 Fluorescence Recovery af ter Photobleaching (FRAP) 8.2.1 Mark et Trends 8.2.2 Mark et Forecast 8.3 Fluorescence Resonance Energy Transfer (FRET) 8.3.1 Mark et Trends 8.3.2 Mark et Forecast 8.4 High Content Screening (HCS) 8.4.1 Mark et Trends 8.4.2 Mark et Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Mark et Forecast For more information, visit : https://www.imarcgroup.com/live -cell-imaging-market/toc
- 11. Disclaimer © 2023 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
- 12. Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com